Companies: 10,795·Total market cap: $144.5T
Polyrizon Ltd.

Polyrizon Ltd.

PLRZNASDAQHealthcare● Active
$12.52
$-0.47(-3.62%)
Market Cap$14025029
P/E Ratio—
52W High$18.2
52W Low$2.88
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Polyrizon Ltd. (PLRZ) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001893645 · PLRZ · NASDAQ · as of Jun 8, 2026

Filing snapshot

178
Total Filings
6-K
Latest Form
2026-06-08
Most Recent
2024
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001893645 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-03-25
Fiscal Year End
Mar 25, 2026
Accession No.
0001213900-26-034198
Primary Document
ea0282602-20f_polyrizon.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001893645 · Accession 0001213900-26-034198

Latest Key Filings

6-KQuarterly Report
REPORT OF FOREIGN PRIVATE ISSUER
2026-06-08
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-06-08
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-06-08
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-06-05
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-27
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-13
View
EFFECTEFFECT
EFFECT
2026-05-04
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-04
View
CORRESPCORRESP
CORRESP
2026-04-30
View
F-1/AF-1/A
AMENDMENT NO. 1 TO FORM F-1
2026-04-30
View
UPLOADUPLOAD
UPLOAD
2026-04-28
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-04-28
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-27
View
DD
D
2026-04-23
View
F-1F-1
REGISTRATION STATEMENT
2026-04-23
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-08
View
Showing 1–15 of 172 filingsForm 4 / 144 hidden· 178 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001893645  |  Exchange: NASDAQ · Healthcare

Polyrizon Ltd. (NASDAQ: PLRZ) has submitted 178 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2024. As a Healthcare sector company with CIK 0001893645, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Polyrizon Ltd.'s most comprehensive regulatory disclosure. The most recent Polyrizon Ltd. 10-K was filed on 2026-03-25 for fiscal year ending 2026. Historical PLRZ 10-K annual reports are available from 2022 through 2026.

Investors researching Polyrizon Ltd. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
NBY SEC Filings →CYCN SEC Filings →VYNE SEC Filings →RADX SEC Filings →XTLB SEC Filings →TCRT SEC Filings →PMCB SEC Filings →KTTA SEC Filings →
→ PLRZ Financials→ PLRZ Earnings→ PLRZ Insider Trades

Frequently Asked Questions

PLRZ SEC Filings · 8 questions

Polyrizon Ltd. (PLRZ) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 178 filings and access original documents at no cost. Polyrizon Ltd.'s CIK is 0001893645.

PLRZ SEC filingsPolyrizon Ltd. SEC documentsfind PLRZ 10-K